Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy.

Grace HsuCiera BernhardiJustin LawsonVu H DuongAshkan EmadiSandrine NiyongereAlison P Duffy

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Patients with acute leukemia receiving multi-day intensive chemotherapy are at high risk for CINV. The limited data in this study suggests that olanzapine use within a steroid-sparing antiemetic regimen was well tolerated and associated with similar incidence and severity of CINV compared to the control group.

Keyphrases

chemotherapy induced
robot assisted
risk factors
big data
minimally invasive
deep learning
data analysis